Characterization of a non-addictive small molecule therapeutics for the management of non-cancer pain
Ended Purchase Order Awarded
- Contract number
- 75N95C21P00111
- Awardee
-
Eurofins Panlabs Discovery Services Taiwan, LTD. UEI N8VQW3HFJ385
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $13,327
Award facts
- Contract value 100% obligated
- $13,327.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N95C21P00111?
75N95C21P00111 was awarded to Eurofins Panlabs Discovery Services Taiwan, LTD. by National Center for Advancing Translational Sciences (National Institutes of Health) on August 31, 2021.
How much is contract 75N95C21P00111 worth?
The government has obligated $13,327 on 75N95C21P00111.
Was contract 75N95C21P00111 competed?
The extent of competition for 75N95C21P00111 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award